Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ·Healthcare·Biotechnology
$297.70
+1.94%
Mkt Cap $5.96B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (20 analysts)
$291.00
Range $252.00 – $332.00
Implied Upside
-2.3%
Consensus $291.00 vs current $297.70